Bio4Comp · Project

Biological Computers That Solve Problems Too Hard for Traditional Machines

digitalPrototypeTRL 4Thin data (2/5)

Imagine you have a maze with millions of possible paths and you need to find the right one. A regular computer tries them one by one — painfully slow. Bio4Comp built tiny nanoscale networks and let thousands of biological protein filaments explore all paths at the same time, like releasing thousands of ants into a maze simultaneously. The kicker? This biological approach uses orders of magnitude less energy than a conventional computer. The team built working devices that can solve real mathematical problems (called 3-SAT and EXACT COVER) that would choke a normal processor.

By the numbers

EUR 6,084,949

EU funding for biocomputation scale-up research

consortium partners across 4 countries

total project deliverables produced

functional prototype device types (3-SAT and EXACT COVER)

orders of magnitude

less energy than conventional computers

The business problem

What needed solving

Many critical business problems — fleet routing, production scheduling, supply chain optimization — belong to a class of mathematical problems that conventional computers cannot solve efficiently. As problem size grows, computing time and energy costs explode exponentially. Companies either accept suboptimal solutions or spend enormous amounts on high-performance computing infrastructure with massive energy bills.

The solution

What was built

The team built functional nanofabricated devices that solve hard combinatorial problems (3-SAT and EXACT COVER) using biological protein filaments as parallel computing agents. They delivered 10 total deliverables including 2 demonstrated device types, and worked on algorithms to expand the range of solvable problem classes.

Audience

Who needs this

Large logistics companies with complex routing and scheduling optimization problemsPharmaceutical firms running combinatorial molecular screeningData center operators seeking radically lower energy consumption for computationFinancial services firms solving portfolio optimization and risk modeling problemsManufacturing companies optimizing production scheduling across multiple constraints

Business applications

Who can put this to work

Logistics & Supply Chain

enterprise

Target: Large logistics or route-optimization companies

If you are a logistics company dealing with fleet routing and scheduling problems that grow exponentially as you add stops — this project developed biocomputation devices that solve combinatorial optimization problems in parallel. Their 3-SAT and EXACT COVER devices tackle exactly the class of problems behind vehicle routing and warehouse allocation, using orders of magnitude less energy than conventional computing.

Pharmaceutical & Drug Discovery

enterprise

Target: Pharma companies running molecular screening or compound optimization

If you are a pharma company dealing with the combinatorial explosion of molecular combinations during drug screening — this project built nanofabricated network devices where biological agents explore solution spaces in parallel. Their demonstrated EXACT COVER devices address the same mathematical structure as molecular docking and compound selection problems, potentially accelerating early-stage discovery pipelines.

Semiconductor & High-Performance Computing

enterprise

Target: Data center operators or chip design firms seeking energy-efficient computing

If you are a data center operator struggling with power consumption and heat dissipation costs — this project demonstrated a computing approach that uses orders of magnitude less energy than conventional processors. With 6 partners across 4 countries and EUR 6,084,949 in EU funding, the consortium built functional prototype devices that solve hard combinatorial problems without the thermal overhead of silicon.

Frequently asked

Quick answers

What would it cost to license or access this biocomputation technology?

The project was funded with EUR 6,084,949 in EU public funding under an RIA (Research and Innovation Action), meaning results are typically available for licensing through the coordinating university (Lunds Universitet, Sweden). Specific licensing terms would need to be negotiated directly with the consortium. As a publicly funded project, there may be obligations for fair and reasonable access.

Can this scale to industrial-size problems?

A core goal of Bio4Comp was to demonstrate scalability by increasing problem size by several orders of magnitude beyond their initial proof-of-principle. They delivered functional 3-SAT and EXACT COVER devices, which are the building blocks for larger-scale computation. However, the technology is still at the prototype stage and not yet at industrial production scale.

Who owns the IP and how can I access it?

The project was coordinated by Lunds Universitet (Sweden) with 6 partners across 4 countries. IP ownership typically follows the Horizon 2020 grant agreement, where each partner owns the IP they generate. For licensing discussions, the coordinator in Sweden would be the first point of contact.

What types of problems can this actually solve?

The team built working devices for two specific problem classes: 3-SAT (satisfiability problems) and EXACT COVER. These are NP-complete problems, meaning any problem in that class can be translated into one of these formats. Real-world applications include scheduling, routing, resource allocation, and combinatorial optimization.

How does the energy consumption compare to conventional computing?

According to the project objective, this approach uses orders of magnitude less energy than conventional computers. This directly addresses the growing power consumption and heat dissipation challenges facing data centers and high-performance computing facilities. Exact energy benchmarks at scale would need to be discussed with the consortium.

What is the timeline to a commercially usable product?

The project ran from 2017 to 2022 and produced functional prototype devices. The consortium also worked on developing a roadmap for market acceptance. Based on available project data, the technology is at a demonstrated prototype stage and would likely need several more years of engineering before a commercial product emerges.

Are there regulatory hurdles for deploying biological computing?

Since this technology uses protein filaments and molecular motors in sealed nanofabricated devices (not living organisms or GMOs), regulatory barriers are expected to be lower than for other biological technologies. However, manufacturing standards and certifications for a new computing platform would still need to be established. Based on available project data, the consortium was already working on structuring an ecosystem to accelerate market acceptance.

Consortium

Who built it

The Bio4Comp consortium brings together 6 partners from 4 countries (Germany, Israel, Sweden, UK), led by Lunds Universitet in Sweden. The mix is heavily academic — 4 universities and 1 research organization — with only 1 industry partner (17% industry ratio) and 1 SME. For a business buyer, this signals strong scientific depth but limited commercial readiness. The EUR 6,084,949 budget is substantial for a research action, and the international spread across leading research nations adds credibility. However, the low industry involvement means commercial translation will require new partnerships with hardware manufacturers or computing companies willing to take on the engineering work needed to move from lab prototypes to products.

LUNDS UNIVERSITETCoordinator · SE
LINNEUNIVERSITETETparticipant · SE
BAR ILAN UNIVERSITYparticipant · IL
TECHNISCHE UNIVERSITAET DRESDENparticipant · DE

How to reach the team

Lunds Universitet, Sweden — reach out through university technology transfer office

Order a report on this consortium See LUNDS UNIVERSITET profile →

Next steps

Talk to the team behind this work.

Want an introduction to the Bio4Comp team? SciTransfer can connect you with the right researchers to discuss licensing, collaboration, or pilot opportunities.

Order a report on this topic More in Digital & ICT